Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
Recruiting · NCT04747236 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL | mature T-cell and NK-cell non-Hodgkin lymphoma | Recruiting | Phase 2 | 2026-01-21 | NCT04747236 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Celgene | 53 |
| University of Virginia | 201 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University | Durham | United States | 160 |
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |
| The Ohio State University | Columbus | United States | 191 |
| University of Virginia | Charlottesville | United States | 5 |
| VA Long Beach Health Care System | Long Beach | United States | 2 |
| Yale Cancer Center | New Haven | United States | 31 |